These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 2809757
1. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans. Léveillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC. J Nucl Med; 1989 Nov; 30(11):1902-10. PubMed ID: 2809757 [Abstract] [Full Text] [Related]
2. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates. Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, O'Leary DH, Watson AD, Ganey MV, Morgan RA, Williams SJ. J Nucl Med; 1989 Nov; 30(11):1892-901. PubMed ID: 2809756 [Abstract] [Full Text] [Related]
3. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. Léveillé J, Demonceau G, Walovitch RC. J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328 [Abstract] [Full Text] [Related]
4. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan RA, Goldsmith SJ. J Nucl Med; 1989 May; 30(5):599-604. PubMed ID: 2497233 [Abstract] [Full Text] [Related]
5. [Phase I clinical study of 99mTc-ECD]. Kubo A, Nakamura K, Tsukatani Y, Sanmiya T, Shimizu S, Yokoyama K, Hashimoto S, Torizuka K. Kaku Igaku; 1992 Aug; 29(8):1019-27. PubMed ID: 1434082 [Abstract] [Full Text] [Related]
6. Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers. Walovitch RC, Franceschi M, Picard M, Cheesman EH, Hall KM, Makuch J, Watson MW, Zimmerman RE, Watson AD, Ganey MV. Neuropharmacology; 1991 Mar; 30(3):283-92. PubMed ID: 1906585 [Abstract] [Full Text] [Related]
7. Technetium-99m-ECD brain SPECT in misery perfusion. Shimosegawa E, Hatazawa J, Aizawa Y, Shouji Y, Hachiya T, Murakami M. J Nucl Med; 1997 May; 38(5):791-6. PubMed ID: 9170448 [Abstract] [Full Text] [Related]
8. [Arterial clearance and cerebral uptake of Tc-99m ECD in patients with cerebrovascular disease compared with PET]. Shishido F, Uemura K, Murakami M, Inugami A, Ogawa T, Higano S, Fujita H, Shimosegawa E, Kanno I, Aizawa Y. Kaku Igaku; 1992 Jan; 29(1):27-35. PubMed ID: 1578819 [Abstract] [Full Text] [Related]
9. [Evaluation of brain perfusion SPECT imaging using 99mTc-ECD]. Matsuda H, Kinuya K, Higashi S, Kawasaki Y, Sumiya H, Shuke N, Hisada K, Yamashita J, Yamaguchi N. Kaku Igaku; 1991 Jul; 28(7):701-9. PubMed ID: 1920946 [Abstract] [Full Text] [Related]
10. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Leveille J, Gherardi PG, Moretti JL, Bischof-Delaloye A, Hill TC, Rigo PM. J Nucl Med; 1989 Jun; 30(6):1018-24. PubMed ID: 2661751 [Abstract] [Full Text] [Related]
11. [99mTc-ECD dynamic SPECT in "luxury perfusion" of subacute stroke]. Ogasawara K, Fujiwara S, Yoshimoto T. Kaku Igaku; 1995 Nov; 32(11):1241-7. PubMed ID: 8558792 [Abstract] [Full Text] [Related]
12. Extraction and retention of technetium-99m-ECD in human brain: dynamic SPECT and oxygen-15-water PET studies. Ishizu K, Yonekura Y, Magata Y, Okazawa H, Fukuyama H, Tanaka F, Hattori N, Kitano H, Fujita T, Tamaki N, Konishi J. J Nucl Med; 1996 Oct; 37(10):1600-4. PubMed ID: 8926507 [Abstract] [Full Text] [Related]
13. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET. Tsuchida T, Nishizawa S, Yonekura Y, Sadato N, Iwasaki Y, Fujita T, Matoba N, Magata Y, Tamaki N, Konishi J. J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056 [Abstract] [Full Text] [Related]
14. Metabolism of technetium-99m-L,L-ethyl cysteinate dimer in rat and cynomolgus monkey tissue. Inoue Y, Momose T, Ohtake T, Nishikawa J, Sasaki Y, Waritani T, Inoue M. J Nucl Med; 1997 Nov; 38(11):1731-7. PubMed ID: 9374342 [Abstract] [Full Text] [Related]
16. Age-related changes in the cerebral distribution of 99mTc-ECD from infancy to adulthood. Kuji I, Sumiya H, Niida Y, Takizawa N, Ikeda E, Tsuji S, Tonami N. J Nucl Med; 1999 Nov; 40(11):1818-23. PubMed ID: 10565776 [Abstract] [Full Text] [Related]
17. Development of "super rapid dynamic SPECT," and analysis of retention process of 99mTc-ECD in ischemic lesions: comparative study with 133Xe SPECT. Komatani A, Sugai Y, Hosoya T. Ann Nucl Med; 2004 Sep; 18(6):489-94. PubMed ID: 15515748 [Abstract] [Full Text] [Related]
18. [Clinical usefulness of 99mTc-ECD--a multicenter phase 3 study]. Yonekura Y, Sasaki Y, Kubo A, Tanada S, Momose T, Torizuka K. Kaku Igaku; 1993 Apr; 30(4):397-410. PubMed ID: 8315890 [Abstract] [Full Text] [Related]
19. [Normal cerebral perfusion of 99mTc-ECD brain SPECT--evaluation by an anatomical standardization technique]. Kawashima R, Koyama M, Ito H, Yoshioka S, Sato K, Ono S, Goto R, Sato T, Fukuda H. Kaku Igaku; 1996 Jan; 33(1):69-72. PubMed ID: 8819716 [Abstract] [Full Text] [Related]
20. Simplified quantification of regional cerebral blood flow with 99mTc-ECD SPECT and continuous arterial blood sampling. Yonekura Y, Ishizu K, Okazawa H, Tanaka F, Hattori N, Sadato N, Tsuchida T, Nishizawa S, Tamaki N, Nagamine T, Konishi J, Shibasaki H. Ann Nucl Med; 1996 May; 10(2):177-83. PubMed ID: 8800446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]